We are monitoring the impact of COVID-19 on Asia Pacific Virology Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4932
Share on
Share on

Asia Pacific Virology Market Research Report – Segmented By Type, Application, End User and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4932
Pages: 145

The size of the Asia Pacific Virology Market is expected to grow at a prominent CAGR from 2021 to 2026.

The APAC virology market is expected to grow significantly over the forecast period due to the increasing incidence of hepatitis, STDs, AIDS, and influenza. Extensive virology applications in different therapies such as phage therapy, gene therapy, synthetic biology, and vaccine formulation are adding gasoline due to the increased frequency of illnesses such as hepatitis, STDs, AIDS, and flu. Furthermore, virology specialties such as pediatric virology, computational virology, molecular virology, and others have expanded. Global awareness of programs and excellent research possibilities are likely to increase during the forecast period, favoring the APAC virology market even more.

According to the WHO (World Health Organization), COPD (chronic obstructive lung disease) claimed the lives of around 3.5 million individuals, while asthma affects nearly 235 million people. The key reason driving demand for bacteriology testing and virology markets is the Y-O-Y rise in the population suffering from TB. The worldwide virology market is likely to see considerable expansion due to the rising incidence and prevalence. Increased healthcare spending in established and emerging nations, increased private and public sector expenditures, and technical breakthroughs in this field contribute to the market's rapid expansion. In addition, reimbursement policies in emerging nations and various methods of controlling situations are boosting the virology market in the APAC region.

However, vaccination and medication pricing fluctuations caused by diminishing raw material availability are steadily eroding market demand. The virology market's development pace is also hampered by a lack of competent employees in laboratories to deal with the latest equipment. In addition, the absence of uniformity is a challenge for virology industry competitors. Frequent changes in economic tactics may also have a detrimental influence on the market's growth rate. The government's strict laws and regulations for approving new items that concern people's safety are also deteriorating market growth factors.

This research report on the Asia Pacific Virology market has been segmented and sub-segmented into the following categories.

By Type:

  • Diagnosing Test
  • Viral Infection Controlling Methods
  • Antiviral Chemotherapy
  • Interferons

By Application:

  • Skin and Soft Tissue Infections
  • Respiratory Tract Infections
  • GI Tract Infections
  • Urinary Tract Infections
  • Eye Infections
  • CNS Infections
  • Sexually Transmitted Diseases
  • Perinatal Infections

By End-User:

  • Hospitals
  • Clinics
  • Laboratories
  • Diagnostic Centres
  • Blood Banks
  • Pharmacies

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, various therapies and diagnostic techniques that involve virology as a component are vital drivers. The Asia Pacific market is likely to benefit from the growing use of virology in gene therapy, phage treatment, vaccine development, and other areas. Increased public awareness programs on flu, zika virus, STDs, AIDS, and Ebola virus also propel the market.

With a growing population, the Asia Pacific region is expected to maintain a steady growth rate in the future years. Therefore, investing heavily in hospitals and pharmaceutical firms directly boosts the market's growth rate in this region.

Japan is likely to lead the Asia Pacific Virology market during the forecast period. Incidences of numerous chronic illnesses are on the rise, driving market demand. In addition, government and non-government organizations are taking initiatives to raise knowledge about the availability of various diagnostic and treatment processes, driving the virology market's growth pace.

China has the second-largest market share in the Asia Pacific, after Japan. The advent of new technologies in the medical industry and a focus on producing novel goods are expected to propel the virology market forward. Furthermore, the increase in public and private institutes' investments in pharmaceutical businesses substantially impacts the virology market's growth rate. Increased spending on healthcare services is also one of the reasons driving the market's demand.

KEY MARKET PLAYERS:

Boehringer Ingelheim Corporation, Merck and Co. Inc, GlaxoSmithKline plc, Abbott Laboratories, Novartis International AG, Siemens, Johnson & Johnson, AstraZeneca AB, and Roche. are some of the key players in the Asia Pacific Virology market.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. OVERVIEW
    1. Executive Summary
    2. Key Inferences
  4. DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ANALYSIS
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. MARKET SEGMENTATION
    1. Type
      1. Introduction
      2. Diagnosing Test
        1. DNA Viruses
        2. RNA Viruses
        3. Prions Diagnostic Test
        4. Other Viral Tests
      3. Viral Infection Controlling Methods
        1. Immunoprophylaxis
        2. Active Prophylaxis (Vaccines)
        3. Passive Prophylaxis
      4. Antiviral Chemotherapy
        1. Virucidal Agents
        2. Antiviral Agents
        3. Immunomodulators
      5.                    Interferons
        1. Cytokines
      6. Y-o-Y Growth Analysis, By Type
      7. Market Attractiveness Analysis, By Type                 
      8. Market Share Analysis, By Type
    2. Application           
      1. Introduction
      2. Skin and Soft Tissue Infections
      3. Respiratory Tract Infections
      4. GI Tract Infections
      5. Urinary Tract Infections
      6. Eye Infections
      7. CNS Infections
      8. Sexually Transmitted Diseases
      9. Perinatal Infections
      10. Y-o-Y Growth Analysis, By Application
      11. Market Attractiveness Analysis, By Application
      12. Market Share Analysis, By Application
    3. End User
      1. Introduction
      2. Hospitals
      3. Clinics
      4. Laboratories
      5. Diagnostic Centres
      6. Blood Banks
      7. Pharmacies
      8. Y-o-Y Growth Analysis, By End User
      9. Market Attractiveness Analysis, By End User
      10. Market Share Analysis, By End User
  6. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Asia Pacific
      1. India
      2. China
      3. Japan
      4. South Korea
      5. Australia
      6. New Zealand
      7. Thailand
      8. Malaysia
      9. Vietnam
      10. Philippines
      11. Indonesia
      12. Singapore
      13. Rest of APAC
    3. STRATEGIC ANALYSIS
      1. PESTLE analysis
        1. Political
        2. Economic
        3. Social
        4. Technological
        5. Legal
        6. Environmental
    4. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  7. MARKET LEADERS' ANALYSIS
    1. Johnson & Johnson
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Abbott Laboratories
    3. GlaxoSmithKline plc
    4. Boehringer Ingelheim Corporation
    5. Merck and Co. Inc.
    6. Novartis International AG
    7. Siemens
    8. AstraZeneca AB
    9. Roche
  8. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  9. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  10. APPENDIX
    1. List of Tables
    2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Type, application, end user and region along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Asia Pacific Virology Market, By Type, From 2021 to 2026 (USD Million)
  2. Asia Pacific Diagnosing Test Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Viral Infection Controlling Methods Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Antiviral Chemotherapy Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Interferons Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific Virology Market, By Application, From 2021 to 2026 (USD Million)
  7. Asia Pacific Respiratory Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific GI Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific Urinary Tract Infections Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Eye Infections Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia Pacific CNS Infections Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Sexually Transmitted Diseases Market, By Region, From 2020 TO 2025 (USD MILLION
  13. Asia Pacific Perinatal Infections Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia Pacific Virology Market, By End User, From 2021 to 2026 (USD Million)
  15. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Million)
  16. Asia Pacific Clinics Market, By Region, From 2021 to 2026 (USD Million)
  17. Asia Pacific Laboratories Market, By Region, From 2021 to 2026 (USD Million)
  18. Asia Pacific Diagnostic Centres Market, By Region, From 2021 to 2026 (USD Million)
  19. Asia Pacific Blood Banks Market, By Region, From 2021 to 2026 (USD Million)
  20. Asia Pacific Pharmacies Market, By Region, From 2021 to 2026 (USD Million)
  21. Japan Virology Market, By Type, From 2021 to 2026 (USD Million)
  22. Japan Virology Market, By Application, From 2021 to 2026 (USD Million)
  23. Japan Virology Market, By End User, From 2021 to 2026 (USD Million)
  24. China Virology Market, By Type, From 2021 to 2026 (USD Million)
  25. China Virology Market, By Application, From 2021 to 2026 (USD Million)
  26. China Virology Market, By End User, From 2021 to 2026 (USD Million)
  27. India Virology Market, By Type, From 2021 to 2026 (USD Million)
  28. India Virology Market, By Application, From 2021 to 2026 (USD Million)
  29. India Virology Market, By End User, From 2021 to 2026 (USD Million)
  30. Australia Virology Market, By Type, From 2021 to 2026 (USD Million)
  31. Australia Virology Market, By Application, From 2021 to 2026 (USD Million)
  32. Australia Virology Market, By End User, From 2021 to 2026 (USD Million)
  33. South Korea Virology Market, By Type, From 2021 to 2026 (USD Million)
  34. South Korea Virology Market, By Application, From 2021 to 2026 (USD Million)
  35. South Korea Virology Market, By End User, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample